The Role of Oxidative Stress and the Effects of Antioxidants on the Incidence of Infectious Complications of Chronic Lymphocytic Leukemia

Table 2

Pro- and antioxidant status of the patients.

Pro- and antioxidant status	Patients with CLL treated with antileukemic therapy (group A); Number of patients: 44	Patients with CLL treated with antileukemic therapy and antioxidants (group B); Number of patients: 40
FORD (mmol/L)	0.48–0.96	0.39–0.81	<0.05
FORT (mmol/L)	2.7–3.8	2.5–3.2	NS
Uric acid (mg/dL)
Normal (2–7 mg/dL)	28	16	NS
High	34	6	<0.05